Profiles of Primary Brain Abscesses and Their Impact on Survival: An International ID-IRI Study
Meyha Sahin,Ali Mert,Ahmet Naci Emecen,Natalija Planinc Strunjas,Lenka Fasanekova,Ayse Batirel,Ilad Alavi Darazam,Shabboo Ansari,Ghazaleh Golchoub Firouzjaei,Roman Stebel,Elif Tukenmez Tigen,Buket Erturk Sengel,Olga Dzupova,Maya Belitova,Maha Abid,Nazife Duygu Demirbaş,Serpil Erol,Halil Kul,Abdullah Umut Pekok,Tülay Ünver Ulusoy,Handan Alay,Zahra Mohtasham Amiri,Antonio Cascio,Mehmet Kürşat Karadağ,Entela Kolovani,Nikolay Mladenov,Ergys Ramosaco,Oğuz Reşat Sipahi,Gamze Şanlıdağ,Amani El-Kholy,Gulay Okay,Natalia Pshenichnaya,Mustafa Serhat Şahinoğlu,Sevil Alkan,Mehmet Özdemir,Bilal Ahmad Rahimi,Gulden Eser Karlidag,Şafak Özer Balin,Anna Liskova,Anas Jouhar,Fahad Almajid,Xhumari Artur,Mehmet Çelik,Asfandiyar Khan,Massimiliano Lanzafame,Andrea Marıno,Arzu Şenol,Serkan Oncu,Mustafa Uğuz,Joanna Zajkowska,Hakan Erdem
DOI: https://doi.org/10.1016/j.ijid.2024.107228
2024-08-29
Abstract:Objectives: This study of 331 primary brain abscess (PBA) patients aimed to understand infecting agents, predisposing factors, and outcomes, with a focus on factors affecting mortality. Methods: Data were collected from 39 centers across 16 countries between January 2010 and December 2022, and clinical, radiological, and microbiological findings, along with their impact on mortality, were analyzed. Results: The patients had a mean±SD age of 46.8±16.3 years, with a male predominance of 71.6%. Common symptoms included headache (77.9%), fever (54.4%), and focal neurological deficits (53.5%). Gram-positive cocci were the predominant pathogens, with viridans group streptococci identified as the most frequently isolated organisms. All patients received antimicrobial therapy and 71.6% underwent interventional therapies. The 42-day and 180-day survival rates were 91.9% and 86.1%, respectively. Significant predictors of 42-day mortality included intravenous drug addiction (HR: 6.02, 95% CI: 1.38-26.26), malignancy (HR: 3.61, 95% CI: 1.23-10.58), confusion (HR: 2.65, 95% CI:1.19-5.88), and unidentified bacteria (HR: 4.68, 95% CI: 1.76-12.43). Significant predictors of 180-day mortality included malignancy (HR: 2.70, 95% CI: 1.07-6.81), confusion (HR: 2.14, 95% CI: 1.11-4.15), temporal lobe involvement (HR: 2.10, 95% CI: 1.08-4.08), and unidentified bacteria (HR: 3.02, 95% CI: 1.49-6.15). Conclusion: The risk of death in PBA extends beyond the infection phase, with different factors influencing the 42-day and 180-day mortality rates. Intravenous drug addiction was associated with early mortality, while temporal lobe involvement was associated with late mortality.